Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention

Tadashi Murai MD, Yoshihisa Kanaji MD, Taishi Yonetsu MD, Tetsumin Lee MD, Junji Matsuda MD, Eisuke Usui MD, Makoto Araki MD, Takayuki Niida MD, Mitsuaki Isobe MD, PhD, Tsunekazu Kakuta MD, PhD

Background: Epicardial focal coronary artery stenosis, diffuse coronary disease, and microvascular resistance (MR) may limit coronary flow. The purpose of percutaneous coronary intervention (PCI) is to increase coronary flow by targeting epicardial lesions. After PCI, MR might change and affect coronary flow. We investigated whether PCI influences MR using the index of microcirculatory resistance (IMR) and if pre‐PCI fractional flow reserve (FFR) or MR predicts the post‐PCI change in hyperaemic coronary flow.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of pre‐hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST‐segment elevation myocardial infarction network

Talwinder S. Kahlon MD, Kulpreet Barn MD, Mian Muhammad Ali Akram MD, James C. Blankenship MD, Cinde Bower‐Stout RN, Dave J. Carey PMP, Haiyan Sun MS, Karen Tompkins Weber RN, Kimberly A. Skelding MD, Thomas D. Scott DO, Sandy M. Green MD, Peter B. Berger MD

Background. Pre‐hospital electrocardiograms (ECGs) are believed to reduce time to reperfusion in ST Segment Elevation Myocardial Infarction (STEMI) patients. Little is known of their impact on clinical outcomes in a rural setting. Geisinger regional STEMI network provides percutaneous coronary intervention (PCI) care to over a 100‐mile radius in rural central Pennsylvania.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID)

Annapoorna S. Kini MD, Yuliya Vengrenyuk PhD, Jacobo Pena MD, Takahiro Yoshimura MD, Sadik R. Panwar MD, Sadako Motoyama MD, PhD, Safwan Kezbor MD, Choudhury M. Hasan MD, Sameet Palkhiwala MD, Jason C. Kovacic MD, PhD, Pedro Moreno MD, Usman Baber MD, Roxana Mehran MD, Jagat Narula MD, PhD, Samin K. Sharma MD

Objectives: The aim of this study was to identify the predictors of side branch (SB) ostial stenosis developed after provisional stenting of the main vessel (MV) using optical coherence tomography (OCT).

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Adverse outcome of coarctation stenting in patients with Turner syndrome

Allard T. van den Hoven, Anthonie L. Duijnhouwer MD, Andreas Eicken MD, PhD, Jamil Aboulhosn MD, Christiaan de Bruin MD, PhD, Philippe F. Backeljauw MD; Laurent Demulier MD, Massimo Chessa MD, PhD, Anselm Uebing MD, PhD, Gruschen R. Veldtman MD, PhD, Aimee K. Armstrong MD, Annemien E. van den Bosch MD, PhD

Objectives: This study examines the outcome and procedural outcomes of percutaneous stent angioplasty for aortic coarctation in patients with Turner syndrome (TS).

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term outcomes and re‐interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single‐center study

Patrick M. Sullivan MD, MS, Agustin E. Rubio MD, Troy A. Johnston MD, Thomas K. Jones MD

Objectives: To describe long‐term risk of mortality, aortic insufficiency (AI), and re‐intervention following balloon aortic valvuloplasty (BAV) in pediatric patients and to identify risk factors for re‐intervention.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transcatheter valve implantation for right atrium‐to‐right ventricle conduit obstruction or regurgitation after modified Björk–fontan procedure

Ashish H. Shah, Eric M. Horlick, Andreas Eicken, Jeremy D. Asnes, Martin L. Bocks, Younes Boudjemline, Allison K. Cabalka, Thomas E. Fagan, Stephan Schubert, Vaikom S. Mahadevan, Danny Dvir, Mark Osten, Doff B. McElhinney

Background: The most common reason for reintervention after a Björk modification of the Fontan procedure, in which the right ventricle (RV) is incorporated into the pulmonary circulation by connecting the right atrial (RA) appendage to the RV directly or with an extra‐anatomic graft, is obstruction or regurgitation of the RA–RV connection. Transcatheter implantation of a valved stent is an appealing option for the treatment of RA–RV conduit dysfunction in these patients. In the present study, we assessed early and intermediate results after transcatheter valve implantation within an obstructed or regurgitant RA–RV modified Fontan pathway.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch

Joseph T. Poterucha DO, Nathaniel W. Taggart MD, Jonathan N. Johnson MD, Bryan C. Cannon MD, Allison K. Cabalka MD, Donald J. Hagler MD, Joseph A. Dearani MD, Frank Cetta MD

Objectives: To report our experience with intravascular and hybrid intra‐operative stent placement for baffle obstruction in patients with complete transposition of the great arteries (TGA) after the atrial switch (Mustard/Senning) operation.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial

Maik J. Grundeken MD, Hector M. Garcia‐Garcia MD, PhD, Indulis Kumsars MD, Maciej Lesiak MD, Peter Kayaert MD, Jo Dens MD, Pieter R. Stella MD, PhD, Robbert J. de Winter MD, PhD, Linda L. Laak Philippe Généreux MD, Aaron V. Kaplan MD,PhD, Martin B. Leon MD, Joanna J. Wykrzykowska MD, PhD, Yoshinobu Onuma MD, Patrick W. Serruys MD

Objective: Randomized comparison between the Tryton Side Branch Stent (Tryton Medical, Durham, NC), used in combination with a main branch drug‐eluting stent (DES), and side branch balloon angioplasty (SBBA, in combination with a main branch DES) using intravascular ultrasound (IVUS), and three‐dimensional quantitative coronary angiography (3D‐QCA).

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions

Nadeen N. Faza, Amgad Mentias, Akhil Parashar, Pulkit Chaudhury, Amr F. Barakat, Shikhar Agarwal, Siddharth Wayangankar, Stephen G. Ellis, E. Murat Tuzcu, Samir R. Kapadia

Background: 5% of patients undergoing coronary stenting have an indication for anticoagulation. The aim of our study was to determine the bleeding rates and complications in patients on triple oral antithrombotic therapy (TOAT) after coronary stenting.

01 febrero 2017

AMERICAN HEART JOURNAL. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization

Shiv Kumar Agarwal MD, Srikanth Kasula MD, Ahmed Almomani MD, Yalcin Hacioglu MD, Zubair Ahmed MD, Barry F. Uretsky MD, Abdul Hakeem MD

Aims: Despite optimal angiographic results after percutaneous coronary intervention (PCI), some lesions may continue to produce ischemia under maximal hyperemia. We evaluated the factors associated with persistently ischemic fractional flow reserve (FFR) after angiographically successful PCI.

01 febrero 2017

AMERICAN HEART JOURNAL. Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease

Jonathan D. Newman MD, MPH, Caron B. Rockman MD, Mikhail Kosiborod MD, Yu Guo MA, Hua Zhong PhD, Howard S. Weintraub MD, Arthur Z. Schwartzbard MD, Mark A. Adelman MD, Jeffrey S. Berger MD, MS

Background: Diabetes mellitus (diabetes) is associated with significantly increased risk of peripheral vascular disease. Diabetes is classified as a coronary heart disease (CHD) risk equivalent, but it is unknown whether diabetes is a CHD risk equivalent for peripheral vascular disease. The objective was to evaluate the odds of peripheral arterial disease (PAD) or carotid artery stenosis (CAS) among participants with diabetes, CHD, or both, compared with participants without diabetes or CHD, in a nationwide vascular screening database. We hypothesized that diabetes and CHD would confer similar odds of PAD and CAS.

01 febrero 2017

AMERICAN HEART JOURNAL. Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Edward Koifman MD, Romain Didier MD, Nirav Patel MD, Zack Jerusalem MD, Sarkis Kiramijyan MD, Itsik Ben-Dor MD, Smita I. Negi MD, Zuyue Wang MD, Steven A. Goldstein MD, Michael J. Lipinski MD, PhD

Background: Right ventricular (RV) dysfunction was shown to be associated with adverse outcomes in a variety of cardiac patients and is considered a risk factor for adverse outcome according to the updated Valve Academic Research Consortium criteria.

01 febrero 2017

AMERICAN HEART JOURNAL. Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial

Rohan Shah MD, Eric Yow MS, William Schuyler Jones MD, Louis P. KohlIII MD, Andrzej S. Kosinski PhD, Udo Hoffmann MD, MPH, Kerry L. Lee PhD, Christopher B. Fordyce MD, Daniel B. Mark MD, MPH

Background: The outcomes in patients by visual assessment and quantitative coronary angiography (QCA) for obstructive coronary artery disease (CAD) are not known. Our objectives were to compare visual and QCA estimates of obstructive CAD and to assess their relationship to outcomes in stable patients with symptoms of CAD.

01 marzo 2017

AMERICAN HEART JOURNAL. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial

Heesun Lee MD, Bon-Kwon Koo MD, PhD, Kyung Woo Park MD, PhD, Eun-Seok Shin MD, PhD, Sang Wook Lim MD, PhD, Seung-Woon Rha MD, PhD, Jang-Whan Bae MD, PhD, Dong Woon Jeon MD, PhD

Background: Percutaneous coronary intervention (PCI) has been developed by drug-eluting stent (DES), but stent implantation has brought the issue of stent thrombosis and optimal antiplatelet therapy. Guidelines recommend at least 6- to 12 months of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor such as clopidogrel. Beyond DAPT after PCI with DES, however, there has been still a debate for antiplatelet regimen. Therefore, we report on the upcoming HOST-EXAM trial (NCT02044250), which will evaluate the efficacy and safety of aspirin and clopidogrel monotherapies beyond DAPT after DES implantation.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.